What is the management of phleboliths in the pelvis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Phleboliths in the Pelvis

Pelvic phleboliths require no specific management or intervention as they are benign calcified thrombi in pelvic veins that do not cause clinical symptoms or complications in the vast majority of cases.

What Are Phleboliths?

Phleboliths are calcified thrombi commonly found in pelvic veins. They have the following characteristics:

  • Composed of calcified laminated fibrous tissue with a surface layer continuous with vein endothelium 1
  • Prevalence in adults ranges from 38.9% to 50.1% 2, 1
  • More common in adults over 40 years of age 1
  • More frequently found on the left side of the pelvis than the right 2
  • Generally considered harmless and incidental findings 3

Clinical Significance

Phleboliths are typically asymptomatic and discovered incidentally on imaging studies. The primary clinical significance of phleboliths is their potential to be confused with ureteral calculi on imaging, particularly in the distal ureter where it crosses the iliac vessels 1, 4.

Distinguishing Phleboliths from Ureteral Stones

When evaluating pelvic calcifications on imaging, the following features can help distinguish phleboliths from ureteral stones:

Features suggestive of phleboliths:

  • Central lucency (8%-60% sensitivity, 100% specificity) 1
  • Rounded shape (91% positive predictive value) 1
  • "Comet-tail sign" - irregular tapering soft tissue mass (21%-65% sensitivity, 100% specificity) 1, 4
  • Lower Hounsfield unit values (160-350 HU) compared to ureteral calculi 1

Features suggestive of ureteral stones:

  • Soft-tissue "rim sign" - circumferential ureteral soft tissue edema (50%-77% sensitivity, 92%-100% specificity) 1, 4
  • Geometric shape (100% positive predictive value) 1
  • Secondary signs of obstruction (hydronephrosis, hydroureter, perinephric stranding)

Imaging Modalities for Evaluation

When phleboliths are suspected or need to be distinguished from ureteral stones:

  1. CT abdomen and pelvis without IV contrast is the first-line imaging modality for suspected urolithiasis 5

  2. CT with IV contrast may help differentiate phleboliths from ureteral stones by:

    • Better delineating the "soft tissue rim" sign around ureteral stones
    • Opacifying iliac vessels to confirm arterial calcifications
    • Showing a delayed nephrogram in the setting of obstruction 5
  3. CT urography (CTU) with excretory phase can confirm the ureteral location of a calculus, distinguishing it from adjacent phleboliths 5

Management Recommendations

  1. No specific treatment is required for phleboliths as they are benign findings without clinical significance in most cases

  2. Patient education about the benign nature of these calcifications to alleviate concerns

  3. Documentation in medical records to avoid unnecessary repeat imaging or interventions in the future

  4. Consider further evaluation only if:

    • There is uncertainty about whether a calcification represents a phlebolith or a ureteral stone in a symptomatic patient
    • There are associated symptoms that cannot be explained by other causes

Rare Associations

While phleboliths are generally harmless, in rare cases they may be associated with:

  • Vascular malformations 6
  • Thrombosis (rare case reports) 3
  • Diverticulitis 1

These associations are uncommon and do not warrant specific intervention for the phlebolith itself, but rather management of the underlying condition if symptomatic.

Key Pitfalls to Avoid

  1. Misdiagnosing phleboliths as ureteral stones, leading to unnecessary interventions
  2. Overlooking true ureteral stones by dismissing them as phleboliths
  3. Repeated imaging for known phleboliths, increasing radiation exposure unnecessarily
  4. Causing patient anxiety by inadequately explaining the benign nature of these findings

In conclusion, phleboliths in the pelvis are common, benign findings that require no specific management. The primary clinical challenge they present is distinguishing them from ureteral stones on imaging studies.

References

Research

Frequency and location of pelvic phleboliths.

Clinical radiology, 1980

Research

Pelvic phleboliths and thrombosis.

Virchows Archiv. A, Pathological anatomy and histopathology, 1986

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.